Markets · 1 sources covering this

Swiss Biotech Windward Raises $225 Million in US IPO, Placement

Windward Bio Group AG, raised about $225 million in a US initial public offering that priced at the midpoint of its marketed range, along with a private placement.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·16h ago
Swiss Biotech Windward Raises $225 Million in US IPO, Placement
Windward Bio Group AG, raised about $225 million in a US initial public offering that priced at the midpoint of its marketed range, along with a private placement.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/e36fda3e3e8f15739c02c3af940cd1fb3b2920e1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Swiss Biotech Windward Raises $225 Million in US IPO, Placement"></iframe>

Swiss Biotech Windward Raises $225 Million in US IPO, Placement

How 1 sources are covering this

Swiss Biotech Windward Raises $225 Million in US IPO, Placement

More from Markets

Senegal Bonds Plunge as Budget Row Puts IMF Program at Risk

DraftKings’ Predictions Bet Has Bulls Reeling From Sticker Shock

Trump administration is hiring debt collectors to go after defaulted student-loan borrowers for first time in 6 years

Microsoft Outlook outage stretches into a second day: What to know

Reader

Trust & legal

Across the network